Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
Abstract
The present invention is to provide a novel compound (I) shown below, having the anti-virus activity; particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof. (wherein Z 1 is NR 4 ; R 1 is hydrogen or lower alkyl; X is a single bond, a hetero atom group selected from O, S, SO, SO 2 and NH, or lower alkylene or lower alkenylene in which the hetero atom group may intervene; R 2 is optionally substituted aryl; R 3 is hydrogen, a halogen, hydroxy, optionally substituted lower alkyl etc; and R 4 and Z 2 part taken together forms a ring, to form a polycyclic compound, including e.g., a tricyclic or tetracyclic compound.
Claims
exact text as granted — not AI-modified1 - 56 . (canceled)
57 . A process for preparing an HIV integrase inhibitor comprising a step of cyclizing a compound of Formula XXIX:
wherein:
R 1 and R 3 are each H;
R 2 is phenyl substituted by 1-3 fluorines;
P 1 is selected from the group comprising hydrogen and a hydroxy protecting group;
X is methylene;
n is an integer selected from the group consisting of 1, 2, and 3;
R 16 and R 18 are joined to form an unsubstituted 5- or 6-membered carbocycle; and
R 15 and R 17 are each hydrogen.
58 . The process of claim 57 , wherein the hydroxyl protecting group is selected from the group consisting of acyl, aralkyl, lower alkyl, alkoxyalkyl, lower alkylsulfinyl, arylsulfonyl, and alkoxycarbonyl.
59 . The process of claim 57 , wherein the cyclized compound is a compound of Formula XXX:
60 . The process of claim 59 , further comprising a step of deprotecting the compound of Formula XXX to yield a compound of Formula XXXI:Join the waitlist — get patent alerts
Track US2017145033A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.